Stock Analysis of Becton Dickinson & Co. (PFD- B) (BDXB) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code BDXB
Close 48.16
Change 0.660 / 1.39 %
Volume 2728.03 K
Vol Change 793828 / 41.04 %
IndustryMedical Instruments & Supplies
SectorHealthcare
AIO Strength Index
Technical StrengthBearish
Growth Index Very Low Growth Stock
Value Index Good Value
Profitability Index Very Low Profitability Stock
Stability Index No Significant Stability


Fundamental View of Becton Dickinson & Co. (PFD- B)


Highs/Lows of Becton Dickinson & Co. (PFD- B)
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week49.26 2.23 % 1.54 % 49.4647.1625-May-2330-May-23
Two Week50.22 4.10 % 3.42 % 50.6547.1622-May-2330-May-23
One Month50.56 4.75 % 5.60 % 50.6547.1622-May-2330-May-23
Three Month48.37 0.434 % 5.95 % 50.6547.1622-May-2330-May-23
Six Months49.38 2.47 % 17.48 % 51.547.1603-Jan-2330-May-23
One year51.67 6.79 % 27.52 % 52.5245.8516-Aug-2218-Nov-22
Two year54.5 11.63 % 29.70 % 55.9445.8509-Feb-2218-Nov-22


Technical View of Becton Dickinson & Co. (PFD- B)






Charts of Becton Dickinson & Co. (PFD- B)


Returns of Becton Dickinson & Co. (PFD- B) with Peers
Period / StockBDXBSTSSLUCYQSAMUTRS
1 Week-2.23%-4.31%-1.10%2.60%0%
1 Mth-4.75%-30.15%-23.82%12.16%-99.82%
3 Mth-0.434%-30.30%-52.52%55.14%-99.88%
6mth-2.47%-50.70%-52.86%59.62%-99.97%
1 Year-6.79%-77.24%-89.47%38.91%-99.98%
2 Year-11.63%-82.69%-43.10%-100.00%
5 Years---2113.33%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Becton Dickinson & Co. (PFD- B) with Peers
Ratio / StockBDXBSTSSLUCYQSAMUTRS
PE8.47-0.562-0.325-5.01-0.0232
P/B0.4470.350611.91-49.990.051
ROA3.01-45.83-119807.50-576.91-66.79
ROE6.40-62.36-32292.170-217.71
Debt To Equity0.6350-0.00760.04600
Revenue18870.00 M
6.81 %
0
%
603793
8.49 %
0
%
51693.00 K
2.78 %
Net Income1779.00 M
14.96 %
-7589.57 K
63.58 %
-6146.86 K
8.18 %
-5085.07 K
16.29 %
-33450.00 K
1.94 %


Technicals of Becton Dickinson & Co. (PFD- B) with Peers
Technical / StockBDXBSTSSLUCYQSAMUTRS-
ADX29.5927.2316.1924.4335.70
CMF0.0208-0.227-0.1170.4950.0444
MFI64.5849.9872.8366.662.82
RSI30.6035.5639.5968.6930.41
MACD Abv SignalFalseFalseTrueFalseFalse
Price Above 50 MAFalseFalseFalseTrueFalse-
Price Above 200 MAFalseFalseFalseTrueFalse-


About : Becton Dickinson and Company


Address : 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880
Tel : 201 847 6800
URL : https://www.bd.com
Code : BDXB, Exchange : NYSE, Country : USA
Fiscal Year End : September
IPO date : 21_May_2020
Employee Count : 77000

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.


Note : All Data Generated at the End of Trading Hours (EOD Data)